Search Results 1711-1720 of 14746 for anti-TNF drugs
Dependence is especially likely to occur in patients who take these medicines to relieve frequent headaches. Taking too much of this medicine may also lead to ...
Additionally, this pillar investigates microorganisms with potential therapeutic benefits, validates strategies for gene therapy and analyzes biological age and ...
It is also used to treat an eye condition called endogenous anterior uveitis (eye inflammation). This medicine belongs to the group of medicines known as ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
About this study. The purpose of this study is to evaluate, jointly and independently among patients deemed at higher risk vs. lower risk for disability ...
Drugs and Supplements · Daratumumab And Hyaluronidase-Fihj (Subcutaneous Route) ... treatment) multiple myeloma in patients who have received at least 1 previous ...
Nilotinib belongs to the general group of medicines known as antineoplastics or cancer medicines. It interferes with the growth of cancer cells, ...
Participation eligibility · Any anti-CD20 therapy such as rituximab, ocrelizumab, or ofatumumab less than 9 months prior to screening or during screening; · If an ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Myxredlin. Descriptions. Insulin human regular is a ...
The following information includes only the average doses of these medicines. If your dose is different, do not change it unless your doctor tells you to do so.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.